Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)
暂无分享,去创建一个
C. O’Neill | M. Katz | J. Coates | F. Wininger | Brian R. Vuillemenot | Derek Kennedy | C. Sibigtroth | Jacob D. Taylor | M. Carpentier | W. Young